Our aim is to bring new medicines to market and help make them affordable to New Zealanders. Our local capacity, supply chain and distribution network mean we are well placed to ensure our medicines are readily available to New Zealanders, wherever they are, when they need them.

Our global portfolio has more than 1,400 medicines across a broad range of therapeutic areas, spanning non-communicable and infectious diseases.

Our diverse portfolio delivers trusted, quality medicines that treat nine out of ten of the World Health Organisations' (WHO) leading causes of death with many of our medicines on the WHO Essential Medicines List.

We have a broad portfolio in New Zealand with over 475 registered products. These include key innovation products, prescription and OTC medicines - both branded and generics. In addition we are a leading supplier of medicines that are funded on the Pharmaceutical Schedule.